By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies and Sage Science today announced a co-marketing deal covering each other's technologies for next-generation sequencing applications.

The deal covers Agilent's 2100 Bioanalyzer for detecting and quantifying nucleic acids and Sage's Pippin Prep DNA size selection system. In addition to co-promoting the platforms, the partners will develop application studies that leverage the combined capabilities of the two systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.